Search for: "Eisen v Feder" Results 61 - 75 of 75
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Sep 2009, 1:28 pm
"'On a motion for class certification, the court may consider evidence that may not be admissible at trial.'" Order, citing Mazza, 254 F.R.D. at 616 (citing, in turn, Eisen v. [read post]
13 Mar 2009, 2:00 am
(GenericsWeb) India’s Human Genome Bill (Spicy IP) Indian drugmakers push into US generics market (GenericsWeb) Uganda: Indian generic manufacturers concerned anti-counterfeit legislation may threaten market in Uganda and surrounding territories (Afro-IP) UK: Court of Appeal admonishes counsel for dilatory actions involved in parallel British and EPO proceedings: Eli Lilly & Co v Human Genome Sciences (Hal Wegner) (PatLit) US: President Obama to lift stem cell limits on… [read post]
14 Feb 2009, 11:56 am
Federal Rule of Civil Procedure 23–An Overview Federal Rule of Civil Procedure 23 governs class action practice in federal court. [read post]
10 Feb 2009, 7:11 am
  Complicating the issue is the statement by the United States Supreme Court's decision in Eisen v. [read post]
9 Jul 2008, 5:31 pm
July 1, 2005) ("this Court does not have the authority under the federal rules to even enter such an order"); Contretas v. [read post]
31 Mar 2008, 3:21 am
  The specifics of the antitrust evidence aside, it is now clear, at least in the federal courts, that plaintiffs no longer credibly can cite Eisen v. [read post]
2 Oct 2007, 5:04 am
Accordingly, his claim for breach of contract fails to state a cause of action (Eisen v Feder, 307 AD2d 817, 818 [2003]); Lessoff v Berger, 2 AD3d 127 [2003]). [read post]
31 Jul 2007, 5:15 am
The Second Circuit noted that the Supreme Court subsequently extended American Pipe to cover “class members who opted out after the certification motion was granted, see Eisen v. [read post]